Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
177
-
Total shares
-
62.5M
-
Shares change
-
+1.24M
-
Total reported value, excl. options
-
$1.58B
-
Value change
-
+$33.8M
-
Put/Call ratio
-
7.24
-
Number of buys
-
84
-
Number of sells
-
-85
-
Price
-
$25.24
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2015
178 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q1 2015.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.5M shares
of 115M outstanding shares and own 54.22% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (5.47M shares), VANGUARD GROUP INC (4.35M shares), OAK RIDGE INVESTMENTS LLC (2.67M shares), Champlain Investment Partners, LLC (2.3M shares), Bank of New York Mellon Corp (2.13M shares), SYSTEMATIC FINANCIAL MANAGEMENT LP (1.97M shares), KALMAR INVESTMENTS INC /DE/ (1.95M shares), BlackRock Fund Advisors (1.88M shares), Van Berkom & Associates Inc. (1.78M shares), and BlackRock Institutional Trust Company, N.A. (1.7M shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.